Genetic barrier and variant fitness in hepatitis C as critical parameters for drug resistance development.

Genetic barrier and variant fitness in hepatitis C as critical parameters for drug resistance development.
复制标题

丙型肝炎的遗传屏障和变异适应性是耐药性发展的关键参数

DOI:
10.1016/j.ddtec.2013.12.003
复制
发表时间:
2014
期刊:
Drug discovery today. Technologies
影响因子:
--
通讯作者:
Welsch C.
Welsch C.
中科院分区:
--
文献类型:
--
作者:
Welsch C.

文献摘要

参考文献

被引文献

相似文献

DOI: 10.1038/35020564
发表时间: 2000-08-10
期刊: NATURE
影响因子: 64.8
作者:
Burch, CL;Chao, L
通讯作者: Chao, L
DOI: 10.1046/j.1365-2893.1999.6120139.x
发表时间: 1999-01
影响因子: 2.5
作者:
D. Lavanchy;R. Purcell;F. Hollinger;C. Howard;A. Alberti;M. Kew;G. Dusheiko;M. Alter;E. Ayoola;P. Beutels;R. Bloomer;B. Ferret;R. Decker;R. Esteban;O. Fay;H. Fields;E. Fuller;P. Grob;M. Houghton;N. Leung;S. Locarnini;H. Margolis;A. Meheus;T. Miyamura;M. Mohamed;B. Tandon;D. Thomas;H. T. Head;A. Toukan;P. Damme;A. Zanetti;R. Arthur;M. Couper;R. Amelio;J. Emmanuel;K. Esteves;P. Gavinio;E. Griffiths;Z. Hallaj;C. Heuck;D. Heymann;S. Holck;M. Kane;L. Martinez;F. Meslin;I. Mochny;A. Ndikuyeze;A. Padilla;G. Rodier;C. Roure;F. Savage;G. Vercauteren
通讯作者: D. Lavanchy;R. Purcell;F. Hollinger;C. Howard;A. Alberti;M. Kew;G. Dusheiko;M. Alter;E. Ayoola;P. Beutels;R. Bloomer;B. Ferret;R. Decker;R. Esteban;O. Fay;H. Fields;E. Fuller;P. Grob;M. Houghton;N. Leung;S. Locarnini;H. Margolis;A. Meheus;T. Miyamura;M. Mohamed;B. Tandon;D. Thomas;H. T. Head;A. Toukan;P. Damme;A. Zanetti;R. Arthur;M. Couper;R. Amelio;J. Emmanuel;K. Esteves;P. Gavinio;E. Griffiths;Z. Hallaj;C. Heuck;D. Heymann;S. Holck;M. Kane;L. Martinez;F. Meslin;I. Mochny;A. Ndikuyeze;A. Padilla;G. Rodier;C. Roure;F. Savage;G. Vercauteren
无干扰素治疗方案会流行吗?
DOI: --
发表时间: 2012
期刊: Gastroenterology
影响因子: 29.4
作者:
C. Welsch;S. Zeuzem
通讯作者: S. Zeuzem
DOI: 10.1128/aac.05184-11
发表时间: 2012-04-01
影响因子: 4.9
作者:
Welsch, Christoph;Schweizer, Sabine;Antes, Iris
通讯作者: Antes, Iris
DOI: 10.1056/nejmoa1009482
发表时间: 2011-03-31
期刊: The New England journal of medicine
影响因子: --
作者:
Bacon BR;Gordon SC;Lawitz E;Marcellin P;Vierling JM;Zeuzem S;Poordad F;Goodman ZD;Sings HL;Boparai N;Burroughs M;Brass CA;Albrecht JK;Esteban R;HCV RESPOND-2 Investigators
通讯作者: HCV RESPOND-2 Investigators